Literature DB >> 18987274

Lifestyle and pharmacological approaches to weight loss: efficacy and safety.

George A Bray1.   

Abstract

CONTEXT: Obesity results from a prolonged small positive energy balance, and its treatment needs to reverse this imbalance. EVIDENCE ACQUISITION: Citations retrieved from PubMed and The Handbook of Obesity 2008 were selected to illustrate the points. EVIDENCE SYNTHESIS: Many different diets have been tried to treat obesity, and weight loss occurs with all of them. There is currently no evidence that clearly supports a superiority of one macronutrient composition for diets used for weight loss. The principal effect seems to be the degree of adherence to the prescribed calorie reduction. Lifestyle strategies to modify eating behavior can be used in individual counseling sessions or in groups, both of which are important in helping patients modify their patterns of eating. Physical activity is particularly important in helping patients maintain a weight loss once achieved and is less valuable for weight loss itself. Food intake is controlled through many different mechanisms, but only a few drugs have been developed that tap these mechanisms. Orlistat, which blocks intestinal lipase, is one; sibutramine, a serotonin-norepinephrine reuptake inhibitor, is a second. Surgical approaches provide the most dramatic weight loss and have been demonstrated to reduce long-term mortality and reduce the incidence of diabetes.
CONCLUSIONS: Weight loss can be achieved by many methods, but the surgical procedures appear to be the most durable.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18987274      PMCID: PMC2585762          DOI: 10.1210/jc.2008-1294

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  62 in total

1.  A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women.

Authors:  Bonnie J Brehm; Randy J Seeley; Stephen R Daniels; David A D'Alessio
Journal:  J Clin Endocrinol Metab       Date:  2003-04       Impact factor: 5.958

2.  Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.

Authors:  Luc F Van Gaal; Aila M Rissanen; André J Scheen; Olivier Ziegler; Stephan Rössner
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

3.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

4.  Effects of sibutramine plus orlistat in obese women following 1 year of treatment by sibutramine alone: a placebo-controlled trial.

Authors:  T A Wadden; R I Berkowitz; L G Womble; D B Sarwer; M E Arnold; C M Steinberg
Journal:  Obes Res       Date:  2000-09

5.  Randomized trial on protein vs carbohydrate in ad libitum fat reduced diet for the treatment of obesity.

Authors:  A R Skov; S Toubro; B Rønn; L Holm; A Astrup
Journal:  Int J Obes Relat Metab Disord       Date:  1999-05

6.  Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study.

Authors:  André J Scheen; Nick Finer; Priscilla Hollander; Michael D Jensen; Luc F Van Gaal
Journal:  Lancet       Date:  2006-11-11       Impact factor: 79.321

7.  Effect of sibutramine on weight loss and blood pressure: a meta-analysis of controlled trials.

Authors:  Su Hyun Kim; Young Mee Lee; Sun Ha Jee; Chung Mo Nam
Journal:  Obes Res       Date:  2003-09

8.  Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis.

Authors:  A M Dattilo; P M Kris-Etherton
Journal:  Am J Clin Nutr       Date:  1992-08       Impact factor: 7.045

9.  Physical activity and weight loss: does prescribing higher physical activity goals improve outcome?

Authors:  Robert W Jeffery; Rena R Wing; Nancy E Sherwood; Deborah F Tate
Journal:  Am J Clin Nutr       Date:  2003-10       Impact factor: 7.045

10.  Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial.

Authors:  Christopher D Gardner; Alexandre Kiazand; Sofiya Alhassan; Soowon Kim; Randall S Stafford; Raymond R Balise; Helena C Kraemer; Abby C King
Journal:  JAMA       Date:  2007-03-07       Impact factor: 56.272

View more
  34 in total

Review 1.  The future of obesity reduction: beyond weight loss.

Authors:  Robert Ross; Alison J Bradshaw
Journal:  Nat Rev Endocrinol       Date:  2009-06       Impact factor: 43.330

2.  Metabolic, behavioral, and reproductive effects of vertical sleeve gastrectomy in an obese rat model of polycystic ovary syndrome.

Authors:  Ilana B Ressler; Bernadette E Grayson; Randy J Seeley
Journal:  Obes Surg       Date:  2014-06       Impact factor: 4.129

3.  A prevalence study and description of alli use by patients with eating disorders.

Authors:  Kristine J Steffen; James E Mitchell; Daniel le Grange; Scott J Crow; Evelyn Attia; Cynthia M Bulik; Jocilyn E Dellava; Ovidio Bermudez; Ann L Erickson; Ross D Crosby; Vidhu P Bansal-Dev
Journal:  Int J Eat Disord       Date:  2010-07       Impact factor: 4.861

4.  Prieurianin Causes Weight Loss in Diet-Induced Obese Mice and Inhibits Adipogenesis in Cultured Preadipocytes.

Authors:  Ahmed Kablan; Rudel A Saunders; Maria Szkudlarek-Mikho; Andrew J B Chin; Raul M Bosio; Kazuyuki Fujii; Joseph Shapiro; Khew-Voon Chin
Journal:  J Diabetes Metab       Date:  2010-09-29

Review 5.  Strategies for the prevention of knee osteoarthritis.

Authors:  Ewa M Roos; Nigel K Arden
Journal:  Nat Rev Rheumatol       Date:  2015-10-06       Impact factor: 20.543

6.  A comparative study of five centrally acting drugs on the pharmacological treatment of obesity.

Authors:  H Suplicy; C L Boguszewski; C M C dos Santos; M do Desterro de Figueiredo; D R Cunha; R Radominski
Journal:  Int J Obes (Lond)       Date:  2013-11-29       Impact factor: 5.095

Review 7.  Tackling obesity in knee osteoarthritis.

Authors:  Anita E Wluka; Cate B Lombard; Flavia M Cicuttini
Journal:  Nat Rev Rheumatol       Date:  2012-12-18       Impact factor: 20.543

8.  Response: the effects of low-calorie diets on abdominal visceral fat, muscle mass, and dietary quality in obese type 2 diabetic subjects (korean diabetes j 2009;33:526-36).

Authors:  Hee-Jung Ahn; Kyung-Wan Min
Journal:  Korean Diabetes J       Date:  2010-02-28

Review 9.  Obesity vaccines.

Authors:  Mariana P Monteiro
Journal:  Hum Vaccin Immunother       Date:  2013-12-23       Impact factor: 3.452

10.  The obesity susceptibility gene Cpe links FoxO1 signaling in hypothalamic pro-opiomelanocortin neurons with regulation of food intake.

Authors:  Leona Plum; Hua V Lin; Roxanne Dutia; Jun Tanaka; Kumiko S Aizawa; Michihiro Matsumoto; Andrea J Kim; Niamh X Cawley; Ji-Hye Paik; Y Peng Loh; Ronald A DePinho; Sharon L Wardlaw; Domenico Accili
Journal:  Nat Med       Date:  2009-09-20       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.